http://www.fpnotebook.com/
Erythema Multiforme Major
Aka: Erythema Multiforme Major, Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, Stevens Johnson
- Definitions
- General
- Acute life-threatening hypersensitivity skin reaction
- Stevens Johnson Syndrome
- Affects 10% of body surface area
- Toxic Epidermal Necrolysis
- Affects 30% of body surface area
- Pathophysiology
- Severe clinical variant of Erythema Multiforme
- Previously thought to be part of same spectrum as minor
- Now thought to be clinically distinct
- Epidemiology
- Most common in winter and early spring
- More common in males by 2:1 ratio
- Ages affected most commonly 20-40 years
- Causes
- Medication (50% of Stevens Johnson and 90% of Toxic Epidermal Necrolysis)
- Antibiotics (esp. Sulfa drugs)
- Seizure medications
- NSAIDs
- Vaccinations
- Other causes
- Infectious disease
- Connective tissue disease
- Pregnancy
- Symptoms
- Prodrome (onset 1-3 weeks after causative exposure)
- Fever
- Malaise
- Headache
- Cough
- Sudden widespread skin eruption (onset 1-3 days after exposure)
- See below
- Signs
- Pathognomonic target lesions
- Widespread skin involvement
- See Erythema Multiforme for course and specific description
- Mucosal bullae (severe in 20% of cases)
- Oral Mucosa may lead to inadequate oral intake
- Respiratory may lead to respiratory distress
- Conjunctiva may lead to ocular complications
- Lesion distribution
- Starts on face and trunk and spreads peripherally
- Diagnosis
- Clinical diagnosis
- Skin biopsy can confirm the diagnosis
- Complications
- Secondary infection and Sepsis
- Multiorgan failure (Renal Failure, Respiratory failure)
- Corneal scarring (related to Corneal Ulceration)
- Labs
- No lab tests are specific for Stevens Johnson syndrome
- Management
- Intensive care unit (or burn unit) admission
- Withdraw all potential causative agents
- Fluid Resuscitation
- Wound care
- Antibiotics only where specifically indicated
- IV-Ig has been used in some cases
- Ophthalmology consult
- Prognosis
- Mortality
- Stevens Johnson: 5%
- Toxic Epidermal Necrolysis: 30%
- References
- Parrillo (2007) Curr Allergy Asthma Rep 7(4): 243-7
- Usatine (2010) Am Fam Physician 82(7): 773-80